AmSilk
GermanyEntry
2008
Hold
18yr
Status
Active
Who owns AmSilk?
AmSilk is a German Biotech company, currently owned by Athos since 2025 and 2 other investors.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Most recent investor
MIG CapitalMIG Fonds 5 · 2007 · Evergreen
3 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
StatusActive
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2008 · present
MIG CapitalActive
2008 · present(18yr) · MIG Fonds 5 · 2007 · Evergreen
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Bioindustrial Investments · 1999 · Buyout
AthosActive
2025 · present(1yr) · Athos Evergreen Life Sciences · 2001 · Evergreen
More from MIG Fonds 5
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns AmSilk?
AmSilk is currently owned by Athos, Novo Holdings and 1 other, through MIG Fonds 5, since 2025.
When did Athos and 2 others acquire AmSilk?
Athos and 2 others acquired AmSilk in 2025.
Who has owned AmSilk over time?
AmSilk has been through 3 private-equity ownership periods: MIG Capital · via MIG Fonds 5 · since 2008; Novo Holdings · via Novo Holdings Bioindustrial Investments · since 2021; Athos · via Athos Evergreen Life Sciences · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue